SCHEMBL4692996

SCHEMBL4692996

COc1cc2c(Oc3ccc(Br)cc3F)ncnc2cc1OCc1ccccn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.59
KDR P35968 13/20 0.54
EGFR P00533 6/20 0.54
ERBB2 P04626 1/20 0.53
RET P07949 2/20 0.50
KIF5B P33176 2/20 0.50
PDGFRB P09619 4/20 0.45
FLT4 P35916 4/20 0.45
FLT1 P17948 3/20 0.45
CSF1R P07333 1/20 0.45
FLT3 P36888 1/20 0.45
FGFR1 P11362 1/20 0.45
FGFR2 P21802 1/20 0.45
FGFR4 P22455 1/20 0.45
FGFR3 P22607 1/20 0.45
MET P08581 2/20 0.44
AURKA O14965 1/20 0.44
TEK Q02763 1/20 0.44
AURKB Q96GD4 1/20 0.44
RAF1 P04049 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4421590 0.88 TRPA1 (0.61) TRPA1KDREGFRRETKIF5B
SCHEMBL7145582 0.83 TRPA1 (0.58) TRPA1KDREGFRRETKIF5B
SCHEMBL4421666 0.82 TRPA1 (0.63) TRPA1KDREGFRERBB2RET
SCHEMBL4375675 0.82 TRPA1 (0.63) TRPA1KDREGFRERBB2RET
SCHEMBL4420668 0.81 KDR (0.61) TRPA1KDREGFRERBB2RET
SCHEMBL29195674 0.79 CCR5 (0.51) AURKB
SCHEMBL7145586 0.79 TRPA1 (0.53) TRPA1KDREGFRRETKIF5B
SCHEMBL4375838 0.79 TRPA1 (0.62) TRPA1KDREGFRRETKIF5B
SCHEMBL21408242 0.77 MET (0.58) KDREGFRFGFR2MET
SCHEMBL30216641 0.77 MET (0.58) KDREGFRFGFR2MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed